Literature DB >> 9300240

Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.

L Schaefer1, X Han, C August, F Matzkies, T Lorenz, R M Schaefer.   

Abstract

The obese Zucker rat represents a model of obesity combined with insulin resistance and hyperlipidaemia, which over a period of several months develops spontaneous glomerulosclerosis. The present study addressed the question as to whether glomerular sclerosis was associated with alterations in the degradation of matrix components. In the early phase (up to 6 months) glomeruli from obese rats displayed increased total collagen content (+64%) and decreased gelatinolytic activity (-34%) as compared to lean control animals. This decline in glomerular gelatinolytic activity was due to a reduction in gelatinase B [matrix metalloproteinase (MMP)-9]. Glomerular MMP-9 mRNA was reduced 4.6 +/- 0.6-fold (n = 3; p < 0.05), MMP-9 protein was not detectable by Western blotting and MMP-9 activity was considerably suppressed in gelatin zymograms. MMP-2, in terms of mRNA expression and activity, was unchanged. Tissue inhibitor of metalloproteinases (TIMP)-1 mRNA expression, TIMP-1 protein (immunohistochemistry) and TIMP-1 activity (reverse zymography) were enhanced in glomeruli from obese rats, while TIMP-2 mRNA remained unchanged. Moreover, mRNA for the alpha 1 IV collagen chain was 2.1 +/- 0.8-fold higher in glomeruli isolated from obese animals (n = 3; p < 0.05). These findings indicate that matrix expansion in glomeruli from obese Zucker rats is due to both enhanced synthesis of matrix components as well as reduced degradation by matrix metalloproteinases. Apparently the latter effect is based on a reduction in MMP-9 and up-regulation of its inhibitor TIMP-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300240     DOI: 10.1007/s001250050785

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

1.  Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.

Authors:  Jan M Williams; Jin Zhang; Paula North; Steven Lacy; Michael Yakes; Annette Dahly-Vernon; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

2.  Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.

Authors:  Makiho Sekiuchi; Akihiko Kudo; Kimimasa Nakabayashi; Masami Kanai-Azuma; Yoshihiro Akimoto; Hayato Kawakami; Akira Yamada
Journal:  Clin Exp Nephrol       Date:  2012-05-22       Impact factor: 2.801

3.  Effects of various stages of nephropathy on wound healing in patients with diabetes: an observational cohort study encompassing 731 diabetics.

Authors:  Paula Loewe; Ioannis Stefanidis; Peter R Mertens; Christos Chatzikyrkou
Journal:  Int Urol Nephrol       Date:  2016-02-12       Impact factor: 2.370

4.  Deficient degradation of homotrimeric type I collagen, α1(I)3 glomerulopathy in oim mice.

Authors:  Anna M Roberts-Pilgrim; Elena Makareeva; Matthew H Myles; Cynthia L Besch-Williford; Amanda C Brodeur; Andrew L Walker; Sergey Leikin; Craig L Franklin; Charlotte L Phillips
Journal:  Mol Genet Metab       Date:  2011-07-31       Impact factor: 4.797

5.  Glomerular protein levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 are lower in diabetic subjects.

Authors:  Toby C Cornish; Serena M Bagnasco; Anne M Macgregor; Jie Lu; Elizabeth Selvin; Marc K Halushka
Journal:  J Histochem Cytochem       Date:  2009-06-08       Impact factor: 2.479

6.  Increase in extracellular cross-linking by tissue transglutaminase and reduction in expression of MMP-9 contribute differentially to focal segmental glomerulosclerosis in rats.

Authors:  Senyan Liu; Yuehong Li; Huiying Zhao; Dong Chen; Qiang Huang; Suxia Wang; Wanzhong Zou; Youkang Zhang; Xiaomei Li; Haichang Huang
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

7.  Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress.

Authors:  Giuseppina Palladini; Laura G Di Pasqua; Clarissa Berardo; Veronica Siciliano; Plinio Richelmi; Stefano Perlini; Andrea Ferrigno; Mariapia Vairetti
Journal:  Can J Gastroenterol Hepatol       Date:  2019-02-03

8.  MMPs and TIMPs levels are correlated with anthropometric parameters, blood pressure, and endothelial function in obesity.

Authors:  Soumaya Boumiza; Karim Chahed; Zouhair Tabka; Marie-Paule Jacob; Xavier Norel; Gulsev Ozen
Journal:  Sci Rep       Date:  2021-10-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.